Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKesson
Farmers Insurance
US Army
Johnson and Johnson
Harvard Business School
Boehringer Ingelheim
Covington
Dow

Generated: October 19, 2018

DrugPatentWatch Database Preview

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE Drug Profile

« Back to Dashboard

Which patents cover Butalbital, Acetaminophen And Caffeine, and when can generic versions of Butalbital, Acetaminophen And Caffeine launch?

Butalbital, Acetaminophen And Caffeine is a drug marketed by Aurolife Pharma Llc, Gilbert Labs, Graham Dm, Hikma Pharms, Mallinckrodt, Mayne Pharma Inc, Nexgen Pharma, Nuvo Pharms Inc, Tedor Pharma Inc, Mikart, Abhai Llc, Able, Actavis Labs Ut Inc, Cnty Line Pharms, Lannett Co Inc, Mirror Pharms Llc, Novast Labs, Specgx Llc, Sun Pharm Industries, Vintage Pharms, and Watson Labs. and is included in thirty-one NDAs.

The generic ingredient in BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.

Summary for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Drug patent expirations by year for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Pharmacology for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Synonyms for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
122018-95-5
AC1MIWIF
Acetamide, N-(4-hydroxyphenyl)-, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-(2-methylpropyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
Acetaminophen mixture with butalbital and caffeine
Acetaminophen mixture with caffeine and butalbital
ACETAMINOPHEN, BUTALBITAL AND CAFFEINE
ACETAMINOPHEN, BUTALBITAL, AND CAFFEINE
Alagesic
Amaphen
Americet
Anolor
Arcet
Butace
BUTALBITAL, APAP, AND CAFFEINE
Capacet
DTXSID50153479
Endolor
Esgic Plus
Ezol
HE302168
LS-187804
Medigesic
N-(4-hydroxyphenyl)acetamide; 5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione; 1,3,7-trimethylpurine-2,6-dione
Orbivan
Pacaps
Repan
SCHEMBL2523453
Tencet
Zebutal

US Patents and Regulatory Information for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vintage Pharms BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 040511-001 Aug 27, 2003 AA RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vintage Pharms BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 040513-001 Aug 25, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurolife Pharma Llc BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine CAPSULE;ORAL 204733-001 Sep 26, 2018 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gilbert Labs BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 087629-001 Nov 13, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mirror Pharms Llc BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 040883-001 Dec 23, 2008 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mallinckrodt BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine CAPSULE;ORAL 088758-001 Mar 27, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKesson
Farmers Insurance
US Army
Johnson and Johnson
Harvard Business School
Boehringer Ingelheim
Covington
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.